Hypertension Prevalence, Awareness, and Control in US Adults Before and After the COVID‐19 Pandemic
Essa M, Malik D, Lu Y, Yang H, Spatz E, Krumholz H, Faridi K. Hypertension Prevalence, Awareness, and Control in US Adults Before and After the COVID‐19 Pandemic. Journal Of Clinical Hypertension 2025, 27: e70093. PMID: 40685707, PMCID: PMC12277530, DOI: 10.1111/jch.70093.Peer-Reviewed Original ResearchConceptsHypertension prevalencePrevalence ratiosUS adultsAge-standardized prevalence estimatesAggressive public health effortsPublic health effortsPre-pandemicControl of hypertensionCOVID-19 pandemicHypertension awarenessHealth effortsPoisson regressionImpact of hypertensionPost-pandemicPrevalence estimatesNHANES dataNationwide prevalenceCause of deathUnited StatesBlood pressure controlNational trendsPrevalenceCOVID-19AdultsHypertensionTrends in Prevalence, Treatment, and Relationship of Metabolic Syndrome and Individual Components by Race/Ethnicity, 1999-2018
Lu Y, Li X, Liu Y, Caraballo C, Massey D, Mahajan S, Spatz E, Herrin J, Krumholz H. Trends in Prevalence, Treatment, and Relationship of Metabolic Syndrome and Individual Components by Race/Ethnicity, 1999-2018. JACC Advances 2025, 4: 101785. PMID: 40373521, PMCID: PMC12144450, DOI: 10.1016/j.jacadv.2025.101785.Peer-Reviewed Original ResearchLipid-lowering medication useRacial/ethnic disparitiesMedication useMetS prevalenceRacial/Ethnic DifferencesHispanic individualsAge-standardized prevalence estimatesNational Health and Nutrition Examination SurveyHealth and Nutrition Examination SurveyBlack individualsPersistent racial/ethnic disparitiesFasting GlucoseNutrition Examination SurveyRelationship of metabolic syndromeMetabolic syndromePrescription drug useNationally representative dataExamination SurveyMetS componentsWaist circumferenceEligible individualsTreatment gapRacial/ethnic subgroupsU.S. adultsPrevalence estimates
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply